Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. | 108,572 | reported | 16 Feb 2016 | tx 113+339,649−294,712 |
| Intellia Therapeutics, Inc. | 69,213 | reported | 01 Mar 2024 | tx 45+651,470−124,955 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 01 Mar 2024 | GRANT_AWARD | Intellia Therapeutics, Inc. | 28,628 | 0.00 USD | |
| 01 Mar 2024 | GRANT_AWARD | Intellia Therapeutics, Inc. | 41,316 | 0.00 USD | deriv |
| 03 Jan 2024 | SALE | Intellia Therapeutics, Inc. | 5,365 | 29.46 USD | |
| 01 Jan 2024 | EXERCISE | Intellia Therapeutics, Inc. | 3,062 | — | |
| 01 Jan 2024 | EXERCISE | Intellia Therapeutics, Inc. | 3,062 | 0.00 USD | deriv |
| 01 Mar 2023 | GRANT_AWARD | Intellia Therapeutics, Inc. | 27,484 | 0.00 USD | |
| 01 Mar 2023 | GRANT_AWARD | Intellia Therapeutics, Inc. | 38,834 | 0.00 USD | deriv |
| 04 Jan 2023 | SALE | Intellia Therapeutics, Inc. | 2,427 | 37.21 USD | |
| 01 Jan 2023 | EXERCISE | Intellia Therapeutics, Inc. | 3,062 | — | |
| 01 Jan 2023 | EXERCISE | Intellia Therapeutics, Inc. | 3,062 | 0.00 USD | deriv |
| 01 Jan 2022 | SALE | Intellia Therapeutics, Inc. | 1,013 | 112.24 USD | |
| 01 Jan 2022 | EXERCISE | Intellia Therapeutics, Inc. | 3,062 | — | |
| 01 Mar 2022 | GRANT_AWARD | Intellia Therapeutics, Inc. | 12,720 | 0.00 USD | |
| 01 Mar 2022 | GRANT_AWARD | Intellia Therapeutics, Inc. | 12,720 | 0.00 USD | deriv |
| 01 Jan 2022 | EXERCISE | Intellia Therapeutics, Inc. | 3,062 | 0.00 USD | deriv |
| 07 Sept 2021 | EXERCISE | Intellia Therapeutics, Inc. | 3,482 | 14.58 USD | |
| 07 Sept 2021 | SALE | Intellia Therapeutics, Inc. | 3,482 | 180.12 USD | |
| 07 Sept 2021 | EXERCISE | Intellia Therapeutics, Inc. | 3,482 | 0.00 USD | deriv |
| 30 Aug 2021 | EXERCISE | Intellia Therapeutics, Inc. | 5,200 | 19.27 USD | |
| 30 Aug 2021 | SALE | Intellia Therapeutics, Inc. | 704 | 153.22 USD | |
| 30 Aug 2021 | SALE | Intellia Therapeutics, Inc. | 1,100 | 154.29 USD | |
| 30 Aug 2021 | SALE | Intellia Therapeutics, Inc. | 1,700 | 155.29 USD | |
| 30 Aug 2021 | SALE | Intellia Therapeutics, Inc. | 300 | 156.10 USD | |
| 31 Aug 2021 | SALE | Intellia Therapeutics, Inc. | 24,800 | 160.22 USD | |
| 30 Aug 2021 | SALE | Intellia Therapeutics, Inc. | 300 | 158.42 USD |